TERUMO CORPORATION (4543.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

28.7x

EV/EBITDA

12.6x

Market Cap

JPY 3.64T

MomentumView details →

1D Return

−0.06%

YTD Return

+7.14%

RSI (14)

45.8

ValuationView details →

P/E (Fwd)

28.7x

EV/EBITDA

12.6x

Market Cap

JPY 3.64T

RSI (14)

45.8

MomentumView details →

1D Return

−0.06%

YTD Return

+7.14%

ProfitabilityView details →

Gross Margin

51.18%

Net Margin

11.68%

EBITDA Margin

22.19%

ROE (TTM)

8.40%

ROA (TTM)

5.67%

Asset Turnover

0.53x

GrowthView details →

Revenue YoY

+8.34%

EPS YoY

+2.86%

FCF YoY

—

Revenue CAGR 3Y

+13.79%

EPS CAGR 3Y

−12.38%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.26x

Current Ratio

1.51x

Quick Ratio

0.89x

Div Yield

1.22%

Div Rate

—

Div Growth 1Y

−40.91%

Financials snapshotView financials →

Revenue (TTM)

1.10T

Net Income (TTM)

127.90B

Op. CF (TTM)

208.47B

Next earningsNov 5, 2026 →

Latest newsMore news →

Terumo held a briefing on its newly completed building at the Kofu Plant in Showa-cho, Yamanashi Prefecture, which will double the company's CDMO production capacity and is scheduled to start operations in 2027 as a core hub for supplying biopharmaceuticals domestically and internationally.8h ago

Similar companies

CANON INC.7751.T Lasertec Corporation6920.T NIDEC CORPORATION6594.T KYOCERA CORPORATION6971.T FANUC CORPORATION6954.T TDK Corporation6762.T Find similar companies →

Latest newsMore news →

Terumo held a briefing on its newly completed building at the Kofu Plant in Showa-cho, Yamanashi Prefecture, which will double the company's CDMO production capacity and is scheduled to start operations in 2027 as a core hub for supplying biopharmaceuticals domestically and internationally.8h ago